ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "juvenile dermatomyositis and pediatric rheumatology"

  • Abstract Number: 1276 • ACR/ARHP Annual Meeting 2017

    Nail Fold Capillary Changes Are Associated with Pulmonary, but Not with Cardiac Involvement in Juvenile Dermatomyositis

    Zoltán Barth1,2,3, Thomas Schwartz2,4, Berit Flatø5,6, Akos Koller7,8, May Brit Samersaw-Lund9, Ivar Sjaastad10,11 and Helga Sanner6, 1Bjorknes College, Oslo, Norway, 2Oslo University Hospital and University of Oslo, Institute for Experimental Medical Research, Oslo, Norway, 3Medical School, University of Pecs, Institute for Translational Medicine, Pecs, Hungary, 4Institute for Experimental Medical Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway, 5Institute for Clinical Medicine, University of Oslo, Oslo, Norway, Oslo, Norway, 6Department of Rheumatology, Oslo University Hospital, Rikshospitalet, Oslo, Norway, Oslo, Norway, 7University of Physical Education, Institute of Natural Sciences, Budapest, Hungary, 8Medical School, University of Pecs, Department of Neurosurgery, Pecs, Hungary, 9Oslo University Hospital, Rikshospitalet, Department of Respiratory Medicine, Oslo, Norway, 10Department of Cardiology, Oslo University Hospital, Oslo, Norway, Oslo, Norway, 11Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway, Oslo, Norway

    Background/Purpose: Juvenile dermatomyositis (JDM) is a rare autoimmune disease of unknown origin, characterised primarily by cutaneous rashes and symmetrical weakness of the proximal skeletal muscles.…
  • Abstract Number: 1280 • ACR/ARHP Annual Meeting 2017

    Clinical Outcomes of Juvenile Dermatomyositis Patients Treated with TNF-Inhibitors: A Retrospective Chart Review Katelyn Banschbach1, Ellen Go1 and Stacey Tarvin2, 1Indiana University School of Medicine, 2riley Hospital for Children, Indiana University

    Katelyn Banschbach1, Ellen Go2 and Stacey Tarvin3, 1Indiana University School of Medicine, Indianapolis, IN, 2Pediatrics, Indiana University School of Medicine, Indianapolis, IN, 3Riley Hospital for Children, Indiana University, Indianapolis, IN

    Background/Purpose: To analyze the clinical outcomes of TNF-inhibitors as a steroid-sparing agent in the treatment of juvenile dermatomyositis (JDM). Methods: We performed a retrospective chart…
  • Abstract Number: 28 • Pediatric Rheumatology Symposium 2017

    Dyslipidemia in Juvenile Dermatomyositis

    Arya Kadakia1, Amer Khojah2, Gabrielle A. Morgan3,4, Megan L. Curran5, Irwin Benuck6, Chinag-Ching Huang1, Dong Xu7 and Lauren M. Pachman8,9, 1Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 2Division of Rheumatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 3Cure JM Program of Excellence in Myositis Research, Chicago, IL, 4Rheumatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 5Pediatric Rheumatology, Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, 6Division of Cardiology, Northwestern University Feinberg School of Medicine, Department of Pediatrics, Chicago, IL, 7Program of Excellence in Cure-Juvenile Myositis (JM) Research, Stanley Manne Children’s Research Institute, affiliated with Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, 8Cure JM Program of Excellence in Juvenile Myositis Research, Stanley Manne Children’s Research Institute, affiliated with Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, 9Rheumatology/Immunology, Ann & Robert H. Lurie Children's Hosptial of Chicago, Chicago, IL

    Background/Purpose: Juvenile Dermatomyositis (JDM) is a multisystem pediatric autoimmune disease characterized by chronic inflammation of muscle and skin. Premature atherosclerosis is an important cause of…
  • Abstract Number: 87 • Pediatric Rheumatology Symposium 2017

    Assessment of Endothelial Dysfunction and Atherogenic Risk Factors in Children with Juvenile Dermatomyositis

    Dawn Wahezi1, Emily Liebling2, Jillian Parekh2, Marija Dionizovik-Dimanovski1, Jaeun Choi3 and Qi Gao3, 1Pediatric Rheumatology, Children's Hospital at Montefiore, Bronx, NY, 2Pediatrics, Children's Hospital at Montefiore, Bronx, NY, 3Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Endothelial pulse amplitude testing (Endo-PAT) measures changes in vascular tone by post-occlusive hyperemic response. A reduced hyperemic response suggests endothelial dysfunction and serves as…
  • Abstract Number: 1364 • ACR/ARHP Annual Meeting 2016

    Efficacy and Safety of Tumour Necrosis Factor Antagonists in a Large Cohort of Juvenile Dermatomyositis Patients

    Raquel Campanilho-Marques1,2,3,4, Claire Deakin5, Stephanie Simou6, Lucy R Wedderburn2,7,8, Clarissa Pilkington7,9 and on behalf of Juvenile Dermatomyositis Research Group (JDRG), 1Infection, Inflammation and Rheumatology Section, UCL Institute of Child Health, London, Portugal, 2Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, 3Rheumatology, Santa Maria Hospital, CHLN, Lisbon, Portugal, 4Rheumatology, Instituto Português de Reumatologia, Lisbon, Portugal, 5Infection, Inflammation and Rheumatology Section,, UCL Institute of Child Health, London, United Kingdom, 6Infection, Inflammation and Rheumatology, UCL Institute of Child Health, London, United Kingdom, 7Infection, Inflammation and Rheumatology Section, UCL Institute of Child Health, London, United Kingdom, 8Rheumatology Unit, Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, United Kingdom, 9Paediatric Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom

    Background/Purpose:  Some patients with juvenile dermatomyositis (JDM) have a disease course which is refractory to multiple drug treatments. There is evidence that prolonged disease activity…
  • Abstract Number: 53 • ACR/ARHP Annual Meeting 2015

    Associations Between Race and Income Disparity on Morbidity in Juvenile Dermatomyositis

    Kathryn Phillippi1, Mark Hoeltzel2, Angela Byun Robinson3,4, Susan Kim5 and CARRA investigators, 1Pediatric Infectious Diseases and Rheumatology, Rainbow Babies and Children’s Hospital / Case Medical Center, Cleveland, OH, 2Rheumatology Division, University of Michigan Mott Children's Hospital, Ann Arbor, MI, 3Pediatrics, Rainbow Babies & Children's Hospital / Case Medical Center, Cleveland, OH, 4Pediatric Rheumatology, Rainbow Babies and Childrens Hospital, Cleveland, OH, 5Division of Immunology, Boston Children's Hospital, Boston, MA

    Disclosure: T32 grant: the National Institutes of Health under Ruth L. Kirschstein National Research Service Award T32 AR007505 from the NIH NIAMS. The CARRA Registry is…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology